1. Dept. of Pathology and Institute of Precision Medicine, Jining Medical University, Jining 272067, China. 2. Institute of Breast Research, Jining Medical University, Jining 272067, China. 3. Dept. of Anatomy and Histology, School of Medicine, Nankai University, Tianjin 300071, China. 4. Dept. of Gastrointestinal Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, China. 5. Dept. of Immunology, School of Medicine, Nankai University, Tianjin 300071, China. 6. The First People's Hospital of Zunyi, Zunyi, 563002, China. 7. Dept. of Immunology, Institute of Basic Medical Science, Chinese Academy of Medical Science, School of Basic Medicine Peking Union Medical College, Beijing, 100005, China.
✉ Corresponding author: Wenzhi Shen, Dept. of Pathology and Institute of Precision Medicine & Institute of Breast Research, Jining Medical University, Jining 272067, China. E-mail: shenwenzhijnmc.edu.cn
Citation:
Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, Li J. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum. Theranostics 2021; 11(14):7128-7129. doi:10.7150/thno.62534. https://www.thno.org/v11p7128.htm
Shen, W., Zhang, X., Tang, J., Zhang, Z., Du, R., Luo, D., Liu, X., Xia, Y., Li, Y., Wang, S., Yan, S., Yang, W., Xiang, R., Luo, N., Luo, Y., Li, J. (2021). CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum. Theranostics, 11(14), 7128-7129. https://doi.org/10.7150/thno.62534.
ACS
Shen, W.; Zhang, X.; Tang, J.; Zhang, Z.; Du, R.; Luo, D.; Liu, X.; Xia, Y.; Li, Y.; Wang, S.; Yan, S.; Yang, W.; Xiang, R.; Luo, N.; Luo, Y.; Li, J. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum. Theranostics 2021, 11 (14), 7128-7129. DOI: 10.7150/thno.62534.
NLM
Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, Li J. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum. Theranostics 2021; 11(14):7128-7129. doi:10.7150/thno.62534. https://www.thno.org/v11p7128.htm
CSE
Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, Li J. 2021. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum. Theranostics. 11(14):7128-7129.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.